Literature DB >> 3612464

Congenital fibrosarcoma.

S Blocker, J Koenig, J Ternberg.   

Abstract

Congenital fibrosarcoma is a rare fibrous tissue malignancy occurring most commonly in the extremities (71%), but presenting in axial locations as well (29%). Two of our five patients had lower extremity tumors and three had axial lesions located in the thoracolumbar region and anterior neck. Amputation was considered necessary to treat the extremity tumors. Two of the patients with axial lesions had incomplete resection, which raised the question of adjunctive therapy and prompted this review. Forty-seven additional cases of fibrosarcoma, present at birth or diagnosed within the first 3 months of life, were adequately described and documented in the literature giving a total of 52 cases. There was no sex predominance (male 26, female 20, unknown 6). Thirty-seven (71%) of the patients had extremity lesions. The local recurrence rate for extremity tumors was 32% with metastatic and mortality rates of 8% and 5%, respectively. Axial tumors (15 cases, 29%) had a local recurrence rate of 33%, which is similar to that for extremity lesions, but the metatstatic and mortality rates were 26% each indicating a more aggressive behavior for axial lesions. The overall mortality rate of 11.5% and metastatic rate of 13.5% for congenital fibrosarcoma, are not dissimilar to the figures quoted for older children. This pattern of tumor behavior, therefore, does not seem to warrant a different attitude because of the "congenital" occurrence of the tumor. Surgery must be considered the mainstay of therapy for fibrosarcoma, but there is a need for adjunctive therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3612464     DOI: 10.1016/s0022-3468(87)80123-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  13 in total

1.  Orthopaedic case of the month: Rapidly progressive shoulder soft tissue mass in an 8-week-old girl.

Authors:  Nicole Marie Behnke; Moneil Patel; Tom Davidson; Alexandre Arkader
Journal:  Clin Orthop Relat Res       Date:  2010-12-03       Impact factor: 4.176

2.  Long-term follow-up of cancer in neonates and infants: a national survey of 142 patients.

Authors:  Andrew B Pintér; Andrew Hock; Pál Kajtár; Ilona Dóber
Journal:  Pediatr Surg Int       Date:  2003-04-17       Impact factor: 1.827

3.  Cytogenetic characterization of congenital or infantile fibrosarcoma.

Authors:  P Dal Cin; P Brock; M Casteels-Van Daele; I De Wever; B Van Damme; H Van den Berghe
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

4.  Clinical management of infantile fibrosarcoma: a retrospective single-institution review.

Authors:  Lalit Parida; Israel Fernandez-Pineda; John K Uffman; Andrew M Davidoff; Matthew J Krasin; Alberto Pappo; Bhaskar N Rao
Journal:  Pediatr Surg Int       Date:  2013-05-26       Impact factor: 1.827

Review 5.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

6.  Radiologic-Pathologic Conference of Children's Hospital Boston: chest wall mass in an infant with eczema.

Authors:  J R Dwek; H P Kozakewich; G A Taylor
Journal:  Pediatr Radiol       Date:  1996

7.  Infantile fibrosarcoma: radiological and clinical features.

Authors:  S J Vinnicombe; C M Hall
Journal:  Skeletal Radiol       Date:  1994-07       Impact factor: 2.199

8.  Spontaneous regression of neonatal fibrosarcoma.

Authors:  N P Madden; R D Spicer; E B Allibone; I J Lewis
Journal:  Br J Cancer Suppl       Date:  1992-08

9.  Primary colonic congenital infantile fibrosarcoma presenting as meconium peritonitis.

Authors:  Saleem Islam; Oliver S Soldes; Robert Ruiz; James D Geiger
Journal:  Pediatr Surg Int       Date:  2008-02-05       Impact factor: 1.827

10.  Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Authors:  Alanna J Church; Monica L Calicchio; Valentina Nardi; Alena Skalova; Andre Pinto; Deborah A Dillon; Carmen R Gomez-Fernandez; Namitha Manoj; Josh D Haimes; Joshua A Stahl; Filemon S Dela Cruz; Sarah Tannenbaum-Dvir; Julia L Glade-Bender; Andrew L Kung; Steven G DuBois; Harry P Kozakewich; Katherine A Janeway; Antonio R Perez-Atayde; Marian H Harris
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.